Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bolt Biotherapeutics, Inc. (BOLT) vs Can-Fite Biopharma Ltd (CANF)

Bolt Biotherapeutics, Inc. and Can-Fite Biopharma Ltd are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Can-Fite Biopharma Ltd are of similar size ($6.9M and $6.5M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −3.36%. Bolt Biotherapeutics, Inc. has the higher net margin (−611.5% vs −1,148.6%) and the lower return on invested capital (−143.8% vs 0.00%). Across the 18 metrics below, Bolt Biotherapeutics, Inc. leads on 10 and Can-Fite Biopharma Ltd on 8.

Valuation

Metric BOLT CANF Biotechnology median
P/E n/m n/m 7.88
P/S 1.32 12.74 11.47
P/B 0.49 2.03 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.48 3.65 10.73
Earnings yield (447.96%) (596.58%) (28.84%)
Free cash flow yield (496.60%) (193.97%) (23.03%)

Profitability

Metric BOLT CANF Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (654.53%) 0.00% 0.00%
Net margin (611.47%) (1,148.62%) 0.00%
Free cash flow margin (655.72%) 0.00% 0.00%
Return on equity (111.65%) 0.00% (57.72%)
Return on assets (49.62%) 0.00% (49.22%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT CANF Biotechnology median
Revenue growth (TTM) 12.79% (3.36%) 5.64%
EPS growth (last fiscal year) 45.91% 45.23% —
Revenue growth, 5-year CAGR 101.61% (11.90%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BOLT CANF Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 3.60 4.73
Net debt to EBITDA 0.21 0.86 0.96

Dividend

Metric BOLT CANF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BOLT CANF Biotechnology median
Market cap 6.92m 6.54m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack